What are Mission Vision & Core Values of Elanco Company?

What drives Elanco's global impact?

Mission and vision statements are crucial strategic foundations for any organization, outlining its purpose, aspirations, and guiding principles. They serve as a compass, directing business decisions, shaping corporate identity, and fostering a unified culture, all contributing to sustained success.

Elanco Animal Health Incorporated, a global leader in animal health, demonstrates the significance of these foundational statements. The company innovates, offering a diverse portfolio of solutions for farm animals and pets, including vaccines, parasiticides, antimicrobials, and digital tools. With the global animal health market valued at USD 62.89 billion in 2024 and projected to grow at a CAGR of 10.46% from 2025 to 2030, Elanco's mission, vision, and values are vital for navigating this dynamic landscape and strengthening its position as a key player. These guiding principles are central to Elanco's strategic framework, influencing everything from product development, such as understanding the Elanco BCG Matrix, to market expansion, ensuring alignment across its global operations.

Elanco's mission statement is concise yet comprehensive, focusing on the profound impact of animal health on human well-being. The key components of this mission statement are evident in its operations. Target customers include both farm animals (livestock) and pets, as well as the farmers, veterinarians, and pet owners who care for them. The products and services offered encompass a broad range, such as vaccines, parasiticides, antimicrobials, and specialized treatments, alongside analytics and digital tools that optimize animal care and productivity. The market scope is global, reflecting Elanco's position as a multinational leader. The unique value proposition lies in its dedication to improving animal health and well-being, strengthening the human-animal bond, and supporting the sustainability of the global food supply. This aligns with the overall Owners & Shareholders of Elanco objectives.

Sustainable Food Production

Elanco's development of Bovaer®, a methane-reducing feed additive for cattle, directly supports the 'food' aspect of their mission by contributing to sustainable food production and addressing climate action, aligning with UN Sustainable Development Goal 13.

Enhancing Companionship

In the companion animal sector, the launch of products like Zenrelia for allergic dermatitis in dogs exemplifies their commitment to 'companionship,' improving the quality of life for pets and strengthening the human-animal bond.

Customer-Centric Approach

The Elanco mission is highly customer-centric, addressing the needs of farmers, veterinarians, and pet owners, ensuring their solutions meet real-world demands.

Innovation Focus

Elanco demonstrates a strong innovation focus, as shown by their significant investment in new product development, achieving $461 million in innovation revenue in 2024.

Future Revenue Targets

Elanco is targeting innovation revenue between $660 million and $740 million for 2025, reflecting their continued commitment to growth and new solutions.

Global Market Leadership

Elanco's global market scope reinforces its position as a multinational leader in animal health, serving diverse markets worldwide.

This mission is clearly reflected in their business operations. For instance, Elanco's development of Bovaer®, a methane-reducing feed additive for cattle, directly supports the 'food' aspect of their mission by contributing to sustainable food production and addressing climate action, aligning with UN Sustainable Development Goal 13. In the companion animal sector, the launch of products like Zenrelia for allergic dermatitis in dogs exemplifies their commitment to 'companionship,' improving the quality of life for pets and strengthening the human-animal bond. The Elanco mission is highly customer-centric, addressing the needs of farmers, veterinarians, and pet owners, while also being innovation-focused, as demonstrated by their significant investment in new product development, achieving $461 million in innovation revenue in 2024 and targeting $660 million to $740 million for 2025. These efforts underscore the Elanco purpose statement and Elanco business philosophy, demonstrating Elanco core values in practice.

Complete Elanco Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

Elanco's vision statement is forward-looking and highly ambitious, aiming for global leadership in animal health. This vision extends beyond animal welfare to include the well-being of people and the planet, reflecting a commitment to the 'One Health' concept, which recognizes the interconnectedness of human, animal, and environmental health. The pursuit of global leadership is supported by Elanco's strategic market expansion, including anticipated product approvals in Europe, the UK, and Australia for key innovations.

Global Leadership

Elanco aims to be the global leader in animal health, a key aspect of the Elanco vision statement.

Animal Well-being

A core focus is advancing the well-being of animals, central to Elanco's purpose statement.

People's Health

The vision encompasses improving human health, aligning with the Elanco company values.

Planet's Health

Elanco is committed to the health of the planet, reflecting its Elanco core values and ethical standards.

Strategic Growth

Strategic market expansion supports the Elanco vision statement and goals.

Innovation Pipeline

A robust pipeline of products drives the Elanco animal health vision and mission.

The vision appears realistic yet aspirational, considering Elanco's current trajectory and market standing. The company reported $4,439 million in revenue for the full year 2024, demonstrating consistent organic constant currency revenue growth. Elanco is actively pursuing a robust pipeline of six potential blockbuster products expected to launch by 2025, each projected to generate over $100 million in annual revenue, which will further solidify its market position. The commitment to advancing the well-being of the planet is underscored by initiatives like the Bovaer® partnership, which could contribute to a livestock sustainability market estimated at $1 billion to $2 billion globally. While achieving global leadership is a continuous endeavor in a competitive market, Elanco's strong innovation pipeline and focus on sustainability-driven solutions provide a credible path towards its ambitious vision. For more insights into the company's strategic focus, consider reading about the Target Market of Elanco.

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

Elanco's core values are fundamental to its identity, guiding its operations and strategic direction. These values, including Integrity, Innovation, Quality, and Collaboration, are complemented by a strong emphasis on Diversity and Inclusion, and Sustainability, shaping the company's culture and impact.

The company's culture is further reinforced by four key behavioral pillars: Involve, Deliver, Own, and Innovate. These principles ensure that Elanco's actions align with its overarching mission and vision, fostering a cohesive and purpose-driven environment.

Integrity

Integrity at Elanco means upholding ethical business practices and transparent reporting. This commitment ensures rigorous testing and compliance with global health regulations for all products, fostering trust with stakeholders.

Innovation

Innovation drives Elanco's ability to address evolving animal health challenges through continuous research and development. The company exceeded its 2024 innovation revenue target, generating $461 million from new products.

Quality

Quality ensures Elanco's products consistently meet high standards for efficacy and safety, critical for animal well-being and food safety. This value is reflected in stringent quality control processes for manufacturing vaccines and treatments.

Collaboration

Collaboration emphasizes working together internally as 'One Elanco' and externally with partners. This is evident in strategic partnerships, such as the one with Purdue University for the One Health Innovation District, expected to open in Q2 2025.

These core values, including Diversity and Inclusion, and Sustainability, are integral to Elanco's operations and strategic direction. For a deeper understanding of the company's journey, explore the Brief History of Elanco. Discover how Elanco's mission and vision further influence its strategic decisions in the next chapter.

Elanco Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

A company's mission and vision are fundamental to its strategic decision-making, providing a compass for its direction and aspirations. These statements not only define purpose but also shape how a company allocates resources and pursues growth opportunities.

Elanco's Mission and Vision: Guiding Strategic Decisions

Elanco's vision to be the global leader in animal health, advancing the well-being of animals, people, and the planet, directly influences its strategic choices. This vision fuels a commitment to innovation, evident in its raised 2025 innovation revenue target of $660 million to $740 million, a significant increase from the $461 million generated in 2024. This financial objective is intrinsically linked to the introduction of 'first-in-class' and 'best-in-class' products, showcasing a clear alignment between financial goals and the company's core mission.

• The vision statement drives strategic focus on innovation and market expansion.
• Financial targets are directly tied to the mission of improving animal health.
• Investment in R&D for advanced treatments is a direct outcome of the vision.
• Portfolio adjustments are made to better serve the mission and vision.

Strategic Investment in Innovation

Elanco's strategic decision to invest $130 million through 2026 in its Elwood, Kansas biologics manufacturing facility exemplifies its commitment to its vision. This expansion is crucial for its monoclonal antibody (mAb) platform, including a potential canine dermatology product slated for 2025, directly supporting the mission of advancing animal well-being through cutting-edge solutions.

Portfolio Streamlining for Focus

The divestiture of its aqua business in 2024 is another strategic move, allowing Elanco to concentrate on high-value opportunities in farm animal and pet retail. This action, which contributed to a debt reduction of approximately $1.3 billion, sharpens the company's focus and enhances its financial capacity to pursue its mission and vision.

Leadership Emphasis on Purpose

Elanco's leadership, including President and CEO Jeff Simmons, consistently reinforces the alignment between business strategy and purpose. Simmons' statement about expecting $600 to $700 million in innovation sales by the end of 2025 highlights the company's dedication to making life better for animals, which in turn improves life for all.

Operationalizing the Vision

The company's business philosophy shapes daily operations by prioritizing research and development in areas like sustainable livestock production and advanced pet care. Long-term planning also involves sustained investment in its product pipeline and strategic alliances that support its 'One Health' approach.

Measurable Success Metrics

Elanco's financial performance in 2024, with a full-year revenue of $4,439 million and 3% organic constant currency growth, alongside a significant improvement in operating cash flow to $541 million, demonstrates the tangible results of its strategically aligned mission and vision.

Understanding Elanco's Business Model

To further understand how these strategic decisions are supported, explore the Revenue Streams & Business Model of Elanco.

These elements demonstrate how Elanco's mission and vision are not merely statements but active drivers of its strategic direction, influencing investment, portfolio management, and operational priorities. Continue reading to explore Core Improvements to Company's Mission and Vision.

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE

Elanco's mission and vision statements are foundational to its identity, guiding its operations and strategic direction. Enhancing these statements can further solidify its market position and stakeholder engagement in the dynamic animal health sector.

Refining the Mission for Innovation Emphasis

Elanco's current mission, 'To enrich lives through food and companionship,' is broad. Incorporating a direct mention of 'innovation' would better reflect its strategic focus, especially considering its significant innovation revenue targets.

Enhancing the Vision with Digital Integration

The vision, 'To be the global leader in animal health, advancing the well-being of animals, people, and the planet,' could be strengthened by acknowledging the growing importance of digital transformation in animal health, a sector projected for significant technological advancement.

Mission Statement Enhancement Example

A refined mission statement could be: 'To enrich lives through food and companionship by pioneering scientific innovation in animal health,' directly highlighting the company's core driver of success.

Vision Statement Enhancement Example

An enhanced vision statement might read: 'To be the global leader in animal health, pioneering innovative and digitally-enabled solutions to advance the well-being of animals, people, and the planet,' reflecting the rapid growth in areas like animal telehealth, which is expected to grow over 17% annually.

These adjustments aim to align Elanco's purpose statements with current market trends and its strategic objectives, such as those detailed in the Growth Strategy of Elanco. By explicitly embracing innovation and digital advancements, Elanco can further solidify its leadership and competitive edge in the evolving animal health landscape.